Skip to content

Scholar Rock SRRK FX Effect on Cash

FX Effect on Cash at other companies

Biogen logo
BiogenBIIB
-$18M-152%
PTC Therapeutics logo
PTC TherapeuticsPTCT
-$1.52M-128%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$1M-200%
Arrowhead Research logo
Arrowhead ResearchARWR
$997K+348%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
-$72K-116%
Cytokinetics logo
CytokineticsCYTK
-$483K-78.9%

Other financials

Income statement

See full
Revenue-
Operating income-$102.0M-32.3%
Net income-$105.5M-41.2%
EPS (diluted)-$0.83-23.9%

Balance sheet

See full
Cash & equivalents$430.5M+212%
Total debt$205.7M+226%
Total equity$276.0M-11.6%
Total assets$535.3M+31.3%

Cash flow

See full
Operating cash flow-$82.1M-4.4%
CapEx$68.0K-74.9%
Free cash flow-$82.2M-4.1%

Valuation

See full
Market cap$6.14B+85.5%

Profitability

See full
Operating margin-231.8%
Net margin-236.9%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-138.9%+60.1pp
Debt / equity0.7×+0.5×
Current ratio8.6×-1.6×

Where this comes from

Reported directly by Scholar Rock in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Scholar Rock’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scholar Rock's fx effect on cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scholar Rock's FX effect on cash?
Scholar Rock (SRRK) reported FX effect on cash of $666K in Q1 2026.
How has Scholar Rock's FX effect on cash changed year-over-year?
Scholar Rock's FX effect on cash increased by 133300.0% year-over-year, from -$500 to $666K.
What does FX effect on cash mean?
The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.